Table 1.
Disease | Cell type | Connexin or Pannexin | References |
---|---|---|---|
Charcot-Marie-Tooth (CMT) | ND | Cx32 | Fairweather et al. (1994), Nelis et al. (1996) |
Oligodendrocytes | Cx32 | Olympiou et al. (2016) | |
Schwann cells and oligodendrocytes | Cx32 | Scherer et al. (1998), Kleopa et al. (2002) | |
Oligodendrocytes | Cx32 and Cx45 | Kunzelmann et al. (1997), Kleopa et al. (2010) | |
Myelination defects and neuronal hyperexcitability | Schwann cells | Cx32 | Sutor et al. (2000) |
Pelizaeus-Merzbacher-like (hypomyelinating leukodystrophy 2) and hereditary spastic paraplegia | Oligodendrocytes | Cx47 | Osaka et al. (2010), Sargiannidou et al. (2010), Tress et al. (2011), Cotrina and Nedergaard (2012), Zlomuzica et al. (2012) |
Oligodendrocyte identity and survival | Oligodendrocytes | Cx47 | Schlierf et al. (2006), Pozniak et al. (2010), Takada et al. (2010), Suzuki et al. (2017) |
Leukodystrophy | Oligodendrocytes Astrocytes | Cx47 | Fasciani et al. (2018) |
Multiple sclerosis | Oligodendrocytes | Cx32 and Cx47 | Markoullis et al. (2012, 2014) |
Experimental autoimmune encephalomyelitis (model of multiple sclerosis) | Oligodendrocytes | Cx32 and Cx47 | Constantinescu et al. (2011) |
Hypomyelinated leukodystrophy | Oligodendrocytes | Cx32 and Cx47 | Wasseff and Scherer (2015) |
Demyelination | Oligodendrocytes | Panx1 | Hainz et al. (2017) |
*This table was intended to show several examples and does not correspond to a compilation of all published evidence. ND, not determined.